Ausgabe 7/2000
Inhalt (6 Artikel)
ORIGINAL ARTICLE
Killing of Fas ligand-resistant renal carcinoma cells by interleukin-2- and BCG-activated effector cells
Sven Brandau, Henrik Suttmann, Hans-Dieter Flad, Dieter Jocham, Andreas Böhle
ORIGINAL ARTICLE
A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity
Carlos Rosales, Viviana Valadez Graham, Gerardo Arrellín Rosas, Horacio Merchant, Ricardo Rosales
ORIGINAL ARTICLE
Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial
Manuela Schmidinger, Günther G. Steger, Catharina Wenzel, Gottfried J. Locker, Thomas Brodowicz, Alexandra C. Budinsky, Christoph Wiltschke, Gero Kramer, Michael Marberger, Christoph C. Zielinski
ORIGINAL ARTICLE
Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer
Patrizia Pellegrini, Ida Contasta, Anna Maria Berghella, Estevano Gargano, Cesare Mammarella, Domenico Adorno
ORIGINAL ARTICLE
Local injections of OK432 can help the infiltration of adoptively transferred CD8+ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines
Katsunori Tatsugami, Koji Tamada, Koichiro Abe, Mamoru Harada, Kikuo Nomoto
ORIGINAL ARTICLE
Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels
Øystein Bruserud, Elling Ulvestad